The rationale for focusing on this axis lies in prior evidence showing that WWOX suppresses RUNX2 activity and thereby reduces metastatic potential in osteosarcoma [4], raising the possibility that a similar mechanism may exist in ES. Here, RUNX2 is linked to osteosarcoma.